J. Jac
Impact in
- Hepatology top 5%
- Liver physiology and pathology
-
- Renal cell carcinoma treatment
- Lung Cancer Treatments and Mutations
Papers in
-
- Renal cell carcinoma treatment 9
- Lung Cancer Treatments and Mutations 3
-
- Renal and related cancers 2
- Fibroblast Growth Factor Research 2
- Co-authors
- Robert J. Amato (8 shared papers)J. P. Willis (7 shared papers)Somyata Saxena (6 shared papers)Joan Hernandez-McClain (6 shared papers)R. J. Amato (9 shared papers)Richard Harrop (4 shared papers)Stuart Naylor (3 shared papers)William Shingler (3 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)Journal of Immunotherapy (2 papers)Clinical Genitourinary Cancer (2 papers)Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
J. Jac
26 papers receiving 792 citations
Peers
Comparison fields: 5 of 64
- Hepatology 110
- Pulmonary and Respiratory Medicine 396
- Cancer Research 142
- Oncology 193
- Immunology 121
Countries citing papers authored by J. Jac
This map shows the geographic impact of J. Jac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Jac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Jac more than expected).
Fields of papers citing papers by J. Jac
This network shows the impact of papers produced by J. Jac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Jac. The network helps show where J. Jac may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Jac, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 166 | |
| 2 | 2007 | 70 | |
| 3 | 2007 | 68 | |
| 4 | 2009 | 64 | |
| 5 | 2008 | 48 | |
| 6 | 2008 | 48 | |
| 7 | 2007 | 47 | |
| 8 | 2008 | 47 | |
| 9 | 2014 | 39 | |
| 10 | 2011 | 38 | |
| 11 | 2011 | 33 | |
| 12 | 2010 | 30 | |
| 13 | 2008 | 22 | |
| 14 | 2008 | 21 | |
| 15 | 2018 | 17 | |
| 16 | 2008 | 9 | |
| 17 | 2006 | 8 | |
| 18 | 2009 | 6 | |
| 19 | 2006 | 6 | |
| 20 | 2008 | 6 |
About J. Jac
J. Jac is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Oncology and Hepatology, having authored 27 papers that have together received 807 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (9 papers), Cancer Genomics and Diagnostics (7 papers), Liver physiology and pathology (5 papers), Lung Cancer Treatments and Mutations (3 papers), Virus-based gene therapy research (3 papers), Renal and related cancers (2 papers), Cancer Diagnosis and Treatment (2 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Hepatology (110 citations), Pulmonary and Respiratory Medicine (396 citations), Cancer Research (142 citations), Oncology (193 citations) and Immunology (121 citations). J. Jac has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Robert J. Amato, J. P. Willis, Somyata Saxena, Joan Hernandez-McClain, R. J. Amato, Richard Harrop, Stuart Naylor, William Shingler, Francis Payumo and Monette Cotreau. Their work appears in journals such as Journal of Clinical Oncology, Journal of Immunotherapy, Clinical Genitourinary Cancer, Molecular Cancer Therapeutics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.